Avalo Therapeutics Stock Analysis

Avalo Stock Analysis Notes

About 73.0% of the company shares are held by institutions such as insurance companies. The company has price-to-book (P/B) ratio of 0.6. Some equities with similar Price to Book (P/B) outperform the market in the long run. Avalo Therapeutics recorded a loss per share of 20.91. The entity had not issued any dividends in recent years. The firm had 1:240 split on the 29th of December 2023. Avalo Therapeutics, Inc., a clinical-stage precision medicine company, discovers, develops, and commercializes targeted therapeutics for patients with unmet clinical need in immunology, immuno-oncology, and rare genetic diseases. Avalo Therapeutics, Inc. was incorporated in 2011 and is headquartered in Rockville, Maryland. Cerecor operates under Biotechnology classification in the United States and is traded on NASDAQ Exchange. It employs 42 people. For more info on Avalo Therapeutics please contact the company at 410 522 8707 or go to https://www.avalotx.com.

Avalo Therapeutics Investment Alerts

Avalo Therapeutics Upcoming and Recent Events

Avalo Largest EPS Surprises

View All Earnings Estimates

Avalo Therapeutics Environmental, Social, and Governance (ESG) Scores

Avalo Stock Institutional Investors

Note, although Avalo Therapeutics' institutional investors appear to be way more sophisticated than retail investors, it remains unclear if professional active investment managers can reliably enhance risk-adjusted returns by an amount that exceeds fees and expenses.

Avalo Market Capitalization

The company currently falls under 'Micro-Cap' category with a current market capitalization of 80.43 M.

Avalo Profitablity

Management Efficiency

Avalo Therapeutics has return on total asset (ROA) of (0.3064) % which means that it has lost $0.3064 on every $100 spent on assets. This is way below average. Similarly, it shows a return on stockholder's equity (ROE) of (0.4252) %, meaning that it created substantial loss on money invested by shareholders. Avalo Therapeutics' management efficiency ratios could be used to measure how well Avalo Therapeutics manages its routine affairs as well as how well it operates its assets and liabilities. Return On Tangible Assets is likely to drop to -0.26 in 2025. Return On Capital Employed is likely to drop to -0.5 in 2025. At this time, Avalo Therapeutics' Total Assets are fairly stable compared to the past year. Non Current Assets Total is likely to rise to about 16.3 M in 2025, despite the fact that Net Tangible Assets are likely to grow to (21.7 M).

Technical Drivers

As of the 24th of March, Avalo Therapeutics shows the mean deviation of 4.37, and Risk Adjusted Performance of (0.01). Avalo Therapeutics technical analysis gives you the methodology to make use of historical prices and volume patterns to determine a pattern that approximates the direction of the firm's future prices.

Avalo Therapeutics Price Movement Analysis

Avalo Therapeutics Insider Trading Activities

Avalo Therapeutics Outstanding Bonds

Avalo Therapeutics Predictive Daily Indicators

Avalo Therapeutics Corporate Filings

Avalo Therapeutics Forecast Models

Avalo Therapeutics' time-series forecasting models are one of many Avalo Therapeutics' stock analysis techniques aimed at predicting future share value based on previously observed values. Time-series forecasting models ae widely used for non-stationary data. Non-stationary data are called the data whose statistical properties e.g. the mean and standard deviation are not constant over time but instead, these metrics vary over time. These non-stationary Avalo Therapeutics' historical data is usually called time-series. Some empirical experimentation suggests that the statistical forecasting models outperform the models based exclusively on fundamental analysis to predict the direction of the market movement and maximize returns from investment trading.

Stock analysis is the technique used by a trader or investor to examine and evaluate how Avalo Therapeutics prices is reacting to, or reflecting on a current market direction and economic conditions. It can be used to make informed decisions about market timing, and when buying or selling Avalo shares will generate the highest return on investment. We also built our stock analysis module to help investors to gain an insight into the world economy as a whole, the stock market, thematic ideas. a specific sector, or an individual Stock such as Avalo Therapeutics. By using and applying Avalo Stock analysis, traders can create a robust methodology for identifying Avalo entry and exit points for their positions.

We track the performance of the top 100 financial experts across various large and mid-size financial boutiques. Avalo analyst recommendations are determined by taking all analyst recommendations and averaging them as Strong Buy, Buy, Hold, Strong Sell or Sell. There is no one specific way to measure analysis performance other than comparing it to the past results via a very sophisticated attribution analysis. Avalo analyst consensus and target price projections should be used in combination with other traditional techniques such as stock price forecasting, technical analysis, earnings estimate, and various momentum models.

Avalo Therapeutics stock analysis indicators help investors evaluate how Avalo Therapeutics stock reacts to ongoing and evolving market conditions. The investors can use it to make informed decisions about market timing and determine when trading Avalo Therapeutics shares will generate the highest return on investment. By understating and applying Avalo Therapeutics stock analysis, traders can identify Avalo Therapeutics position entry and exit signals to maximize returns.

When running Avalo Therapeutics' price analysis, check to measure Avalo Therapeutics' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Avalo Therapeutics is operating at the current time. Most of Avalo Therapeutics' value examination focuses on studying past and present price action to predict the probability of Avalo Therapeutics' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Avalo Therapeutics' price. Additionally, you may evaluate how the addition of Avalo Therapeutics to your portfolios can decrease your overall portfolio volatility.